Most sold healthcare stocks in Q3 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q3 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include PFIZER INC (PFE), TEVA PHARMACEUTICAL-SP ADR (TEVA), MERCK & CO. INC. (MRK), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | -685,511,612 | -$6.3B | 235 | 968 | 1029 | 503 | 2471 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -623,363,087 | -$22.2B | 0 | 4 | 6 | 628 | 18 |
| MRK | MERCK & CO. INC. | -469,688,047 | -$43.2B | 263 | 1360 | 1353 | 580 | 3392 |
| BMY | BRISTOL-MYERS SQUIBB CO | -447,147,447 | -$31.1B | 192 | 874 | 818 | 452 | 2171 |
| GOSS | GOSSAMER BIO INC | -370,230,089 | -$60.8M | 0 | 0 | 1 | 163 | 2 |
| JNJ | JOHNSON & JOHNSON | -310,990,556 | -$75.9B | 197 | 1767 | 1673 | 626 | 4092 |
| VTRS | VIATRIS INC | -273,552,511 | -$3.3B | 92 | 291 | 254 | 258 | 815 |
| ABT | ABBOTT LABORATORIES | -263,098,349 | -$17.6B | 207 | 1033 | 984 | 515 | 2566 |
| GILD | GILEAD SCIENCES INC | -262,222,924 | -$18.6B | 224 | 802 | 696 | 434 | 1986 |
| BSX | BOSTON SCIENTIFIC CORP | -261,190,446 | -$14.7B | 185 | 475 | 437 | 393 | 1219 |
| CVS | CVS HEALTH CORP | -256,867,331 | -$44.3B | 124 | 677 | 632 | 467 | 1659 |
| MDLN | Medline Inc. | -239,123,120 | -$12.4B | 71 | 115 | 81 | 165 | 294 |
| LAB | STANDARD BIOTOOLS INC | -227,849,547 | -$194.1M | 6 | 17 | 21 | 82 | 62 |
| GERN | GERON CORP | -220,755,187 | -$296.1M | 21 | 61 | 34 | 91 | 178 |
| MDT | MEDTRONIC PLC | -216,855,285 | -$13.3B | 186 | 787 | 658 | 423 | 1828 |
| ABBV | ABBVIE INC | -212,687,082 | -$72.7B | 185 | 1601 | 1438 | 576 | 3692 |
| ESPR | ESPERION THERAPEUTICS INC | -204,903,491 | -$645.9M | 0 | 0 | 0 | 183 | 2 |
| UNH | UNITEDHEALTH GROUP INC | -182,138,703 | -$106.2B | 170 | 1080 | 1202 | 686 | 2762 |
| TSHA | TAYSHA GENE THERAPIES INC | -172,393,979 | -$1.4B | 19 | 58 | 32 | 93 | 129 |
| BHC | BAUSCH HEALTH COS INC | -172,122,964 | -$833.4M | 35 | 49 | 40 | 76 | 167 |
| ROIV | ROIVANT SCIENCES LTD | -169,947,617 | -$5.7B | 88 | 163 | 86 | 191 | 373 |
| AVTR | AVANTOR INC | -164,896,433 | $968.1M | 79 | 125 | 111 | 144 | 373 |
| CNC | CENTENE CORP | -161,814,759 | -$12.6B | 145 | 388 | 211 | 270 | 841 |
| EW | EDWARDS LIFESCIENCES CORP | -158,815,640 | -$16.4B | 108 | 369 | 398 | 298 | 1090 |
| ERAS | ERASCA INC | -144,637,788 | -$3.1B | 33 | 79 | 38 | 109 | 166 |
| SHC | SOTERA HEALTH CO | -142,543,384 | -$2.5B | 58 | 121 | 41 | 109 | 250 |
| LFST | LIFESTANCE HEALTH GROUP INC | -139,139,447 | -$1.2B | 62 | 109 | 44 | 98 | 240 |
| SVRA | SAVARA INC | -136,744,563 | -$926.4M | 15 | 46 | 30 | 83 | 106 |
| RLAY | RELAY THERAPEUTICS INC | -135,750,029 | -$2.6B | 27 | 70 | 47 | 100 | 172 |
| ATAI | ATAI LIFE SCIENCES NV | -133,486,145 | -$702.8M | 0 | 0 | 1 | 225 | 3 |
| TALK | TALKSPACE INC | -133,230,830 | -$692.7M | 0 | 2 | 0 | 164 | 2 |
| AVAH | AVEANNA HEALTHCARE HOLDINGS | -128,388,034 | -$828.2M | 50 | 69 | 37 | 88 | 171 |
| DHR | DANAHER CORP | -128,369,879 | -$16.7B | 196 | 620 | 745 | 440 | 1805 |
| IVVD | INVIVYD INC | -127,018,206 | -$111.0M | 22 | 29 | 15 | 58 | 88 |
| TNGX | TANGO THERAPEUTICS INC | -126,856,778 | -$4.4B | 29 | 69 | 36 | 111 | 151 |
| LLY | ELI LILLY & CO | -121,793,442 | -$185.2B | 188 | 1914 | 1363 | 710 | 3958 |
| ALLO | ALLOGENE THERAPEUTICS INC | -121,543,461 | -$354.3M | 21 | 37 | 53 | 89 | 136 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -119,631,460 | $1.2B | 63 | 77 | 64 | 97 | 242 |
| CRNX | CRINETICS PHARMACEUTICALS IN | -118,783,502 | -$4.4B | 0 | 2 | 0 | 248 | 2 |
| IPSC | CENTURY THERAPEUTICS INC | -115,408,415 | -$314.2M | 12 | 16 | 13 | 55 | 56 |
| ELAN | ELANCO ANIMAL HEALTH INC | -114,580,224 | -$3.9B | 69 | 144 | 117 | 167 | 399 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -109,394,560 | -$1.4B | 37 | 76 | 80 | 112 | 228 |
| PALI | PALISADE BIO INC | -104,738,379 | -$258.1M | 12 | 25 | 15 | 68 | 66 |
| CPRX | CATALYST PHARMACEUTICALS INC | -104,024,301 | -$3.3B | 0 | 0 | 1 | 375 | 2 |
| DXCM | DEXCOM INC | -103,917,570 | -$5.1B | 142 | 296 | 295 | 254 | 828 |
| BAX | BAXTER INTERNATIONAL INC | -102,933,668 | -$1.2B | 106 | 187 | 163 | 180 | 580 |
| CTMX | CYTOMX THERAPEUTICS INC | -102,226,418 | -$497.8M | 31 | 43 | 23 | 80 | 124 |
| AMGN | AMGEN INC | -100,210,261 | -$19.0B | 245 | 1062 | 1074 | 481 | 2814 |
| SGRY | SURGERY PARTNERS INC | -97,092,336 | -$1.8B | 24 | 44 | 38 | 75 | 127 |
| BKD | BROOKDALE SENIOR LIVING INC | -95,127,880 | -$2.4B | 37 | 62 | 60 | 118 | 194 |